BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11061057)

  • 1. Transient increase in plasma brain (B-type) natriuretic peptide after percutaneous transluminal coronary angioplasty.
    Tateishi J; Masutani M; Ohyanagi M; Iwasaki T
    Clin Cardiol; 2000 Oct; 23(10):776-80. PubMed ID: 11061057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain natriuretic peptide increases acutely and much more prominently than atrial natriuretic peptide during coronary angioplasty.
    Kyriakides ZS; Markianos M; Michalis L; Antoniadis A; Nikolaou NI; Kremastinos DT
    Clin Cardiol; 2000 Apr; 23(4):285-8. PubMed ID: 10763077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain natriuretic peptide levels during cardiac reperfusion: comparison between percutaneous coronary angioplasty and aorto-coronaric bypass.
    Palazzuoli A; Carrera A; Calabria P; Pastore M; Quatrini I; Vecchiato L; Campagna MS; Palazzuoli V; Nuti R
    Clin Chim Acta; 2004 Apr; 342(1-2):87-92. PubMed ID: 15026268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-type natriuretic peptide and extent of lesion on coronary angiography in stable coronary artery disease.
    Sahinarslan A; Cengel A; Okyay K; Yazici HU; Elbey S; Cemri M; Ozdemir M; Timurkaynak T
    Coron Artery Dis; 2005 Jun; 16(4):225-9. PubMed ID: 15915074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of B-type natriuretic Peptide in patients with unstable angina pectoris or acute myocardial infarction: prognostic significance and therapeutic implications.
    Ahmed W; Zafar S; Alam AY; Ahktar N; Shah MA; Alpert MA
    Angiology; 2007; 58(3):269-74. PubMed ID: 17626979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma B-type natriuretic peptide level can predict myocardial tissue perfusion in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
    Seo SM; Kim S; Chang K; Min J; Kim TH; Koh YS; Park HJ; Shin WS; Lee JM; Kim PJ; Chung WS; Seung KB
    Coron Artery Dis; 2011; 22(6):405-10. PubMed ID: 21701385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial).
    Bonaca MP; Wiviott SD; Sabatine MS; Buros J; Murphy SA; Scirica BM; Rifai N; Antman EM; Morrow DA
    Am J Cardiol; 2007 Feb; 99(3):344-8. PubMed ID: 17261395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-type natriuretic peptide as a predictor of ischemia/reperfusion injury immediately after myocardial reperfusion in patients with ST-segment elevation acute myocardial infarction.
    Arakawa K; Himeno H; Kirigaya J; Otomo F; Matsushita K; Nakahashi H; Shimizu S; Nitta M; Takamizawa T; Yano H; Endo M; Kanna M; Kimura K; Umemura S
    Eur Heart J Acute Cardiovasc Care; 2016 Feb; 5(1):62-70. PubMed ID: 25609593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of serum N-terminal pro-brain natriuretic peptide to predict in-stent restenosis in patients with preserved left ventricular function and normal troponin I levels.
    Hong SN; Ahn Y; Yoon NS; Lee KH; Kim YS; Hwang SH; Lee SR; Kim KH; Park HW; Hong YJ; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC
    Am J Cardiol; 2007 Apr; 99(8):1051-4. PubMed ID: 17437726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rise and fall of B-type natriuretic peptide levels in patients with coronary artery disease and normal left ventricular function after cardiac revascularization.
    Palazzuoli A; Poldermans D; Capobianco S; Giannotti G; Iovine F; Campagna MS; Calabrò A; Bagaglia S; Nuti R
    Coron Artery Dis; 2006 Aug; 17(5):419-23. PubMed ID: 16845249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of myocardial ischemia during percutaneous transluminal coronary angioplasty in patients with significant narrowing of a single coronary artery and stable or unstable angina pectoris.
    Tomai F; Crea F; Gaspardone A; Versaci F; De Paulis R; Penta de Peppo A; Bassano C; Chiariello L; Gioffrè PA
    Am J Cardiol; 1994 Dec; 74(11):1089-94. PubMed ID: 7977064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain natriuretic peptide and other risk markers for outcome assessment in patients with non-ST-elevation coronary syndromes and preserved systolic function.
    Palazzuoli A; Deckers J; Calabrò A; Campagna MS; Nuti R; Pastorelli M; Pasqui AL; Bruni F; Auteri A; Puccetti L
    Am J Cardiol; 2006 Nov; 98(10):1322-8. PubMed ID: 17134622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain natriuretic peptide in the prediction of recurrence of angina pectoris.
    Takase H; Toriyama T; Sugiura T; Ueda R; Dohi Y
    Eur J Clin Invest; 2004 Feb; 34(2):79-84. PubMed ID: 14764069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Women react with more myocardial ischemia and angina pectoris during elective percutaneous transluminal coronary angioplasty.
    Jensen J; Eriksson SV; Lindvall B; Lundin P; Sylven C
    Coron Artery Dis; 2000 Oct; 11(7):527-35. PubMed ID: 11023240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percent change in B-type natriuretic peptide levels during treadmill exercise as a screening test for exercise-induced myocardial ischemia.
    Win HK; Chang SM; Raizner M; Shah G; Al Basky F; Desai U; Plana JC; Mahmarian JJ; Quinones MA; Zoghbi WA
    Am Heart J; 2005 Oct; 150(4):695-700. PubMed ID: 16209968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of balloon inflation-induced acute ischemia on QT dispersion during percutaneous transluminal coronary angioplasty.
    Aytemir K; Bavafa V; Ozer N; Aksoyek S; Oto A; Ozmen F
    Clin Cardiol; 1999 Jan; 22(1):21-4. PubMed ID: 9929750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of acute-phase brain natriuretic peptide in acute myocardial infarction treated with direct coronary angioplasty.
    Katayama T; Nakashima H; Yonekura T; Honda Y; Suzuki S; Yano K
    J Cardiol; 2003 Nov; 42(5):195-200. PubMed ID: 14658407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of minor cardiac troponin I elevation to late cardiac events after uncomplicated elective successful percutaneous transluminal coronary angioplasty for angina pectoris.
    Bertinchant JP; Polge A; Ledermann B; Genet L; Fabbro-Peray P; Raczka F; Brunet J; Poirey S; Wittenberg O; Pernel I; Nigond J
    Am J Cardiol; 1999 Jul; 84(1):51-7. PubMed ID: 10404851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [NT-proBNP and echocardiography for long-term left ventricular function assessment after acute myocardial infarction treated with primary angioplasty].
    Swiatkiewicz I; Grubecki A; Koziński M; Fabiszak T; Białoszyński T; Sukiennik A; Kubica J
    Pol Merkur Lekarski; 2006 Mar; 20(117):289-92. PubMed ID: 16780257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-endorphins during coronary angioplasty in patients with silent or symptomatic myocardial ischemia.
    Falcone C; Guasti L; Ochan M; Codega S; Tortorici M; Angoli L; Bergamaschi R; Montemartini C
    J Am Coll Cardiol; 1993 Nov; 22(6):1614-20. PubMed ID: 8227828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.